Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

But Dr. Williams, whoever he was, didn’t promise glowing, bronzed skin with a pop of a pink pill. Rather, he claimed his product was “the most powerful nerve and spinal tonic in the world.” ...

UI design is a bit tacky Color and glare issues with the screen Runs hot, especially on the glass strip I recently had a brief experience with Samsung’s latest tablet. Starting at a cool $1,000 ...

When it comes to tablet deals, we do our best to highlight top offers from the brands we’re most familiar with. These are noteworthy names like Apple, Samsung, Google, and the focus of today’s ...

The Samsung Galaxy Tab S10 Ultra delivers everything you could reasonably ask from a high-end Android tablet, including a fantastic OLED screen, killer specs, and even a bundled stylus.

As of Nov. 5, both the Amazon Fire HD 8 Kids and the Fire HD 8 Kids Pro tablets are just $69.99 at Amazon, down from the typical price of $139.99. That's an impressive 50% discount or a savings of ...

(NYSE:PFE) stands against the other pharma stocks ... Swiss company Roche, for instance, rejoined the race for a weight-loss pill last year with its acquisition of California-based Carmot ...

LONDON, Nov 4 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Monday its experimental weight-loss pill, licensed a year ago from China's Eccogene for up to $2 billion, was safe and ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

Topless, vomiting, and screaming, Lathers told police officers that she was under the influence of a drug called “tusi,” a pink powder that’s gaining popularity in the US. A toxicology ...

AstraZeneca Plc said its experimental obesity pill was well tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines. The ...